epocrates Appoints New Leaders to Guide Commercial Strategy, Consulting, and Customer Experience Amidst New Wave of Growth

Additions of Andrew Johnson and Bridget Seay strengthen epocrates’ evolution as a commercial organization with best-in-class market intelligence and products

epocrates, an athenahealth, Inc. company that delivers digital clinical decision support to prescribers, announced the expansion of its commercial leadership team to drive the enhancement and development of the company’s commercial product offerings and customer success model. The group recently brought on Andrew Johnson to serve as executive director, commercial strategy, and Bridget Seay to serve as executive director, customer experience & commercial consulting.

“Pharmaceutical marketers are currently under immense pressure to drive meaningful results in an increasingly competitive, digital landscape. In turn, they are looking for consultative services driven by best-in-class market intelligence to help them achieve campaign goals and enhance clinical engagement”

“Pharmaceutical marketers are currently under immense pressure to drive meaningful results in an increasingly competitive, digital landscape. In turn, they are looking for consultative services driven by best-in-class market intelligence to help them achieve campaign goals and enhance clinical engagement,” said Matt Titus, vice president, chief commercial officer, epocrates. “We are thrilled to welcome two experienced leaders to our team who will drive our best-in-class product strategy and our evolution to a customer success model with expert consulting for current and future clients. Additionally, our functional leadership will now have more robust, dedicated support, freeing them up to focus on strategy, sales, customer success, and new market development, while enabling our commercial talent to receive more dedicated management and career development opportunities.”

Johnson will oversee the epocrates sales team supporting the team leads and driving commercial execution for the business. With more than 15 years of sales and leadership experience, he moves to epocrates from athenahealth, where he was named the 2021 athenahealth Sales Leader of the Year and led the athenaPractice sales organization. In that role, he was responsible for many critical aspects of the businesses, such as go-to-market strategy, which included partnerships and value-added resellers.

Seay will lead the solutions design and account management functions, as well as focusing on epocrates’ evolution to a customer success organization. An industry veteran of nearly 20 years, she joins epocrates from Wiley, a global leader in research and education, where she led strategic growth, development, and product lifecycle of the Corporate Partner Solutions advertising portfolio and its evolving Partner Solutions customer base. As part of the role, she also collaborated with key stakeholders to develop strategic capabilities for customers, enabling revenue growth from the corporate customer segment.

“I’ve been following epocrates’ momentum and success for years. epocrates is uniquely positioned to be a major disrupter in the healthcare industry. I couldn’t think of a better time to join epocrates, as we accelerate the company’s growth in new and existing markets. I’m excited to build on all the important work Matt’s team has achieved to date,” said Johnson.

Read More: Stensul is First to Market with an API Integration with Pardot for Email Creation

Seay added, “It’s incredible the rate at which pharma marketing has evolved in recent years and continues to evolve. Changing expectations from clients, emerging technologies, and ever-increasing options across various promotional channels, challenge marketers and media planners today, like never before, to adapt and overcome. I’m committed to alleviating some of those challenges, leading my team to deliver high-quality service to drive the best experience and outcomes for our clients.”

Johnson and Seay’s new roles follow the appointment of Matt Titus as vice president, chief commercial officer, in early 2022, signaling an elevated focus on the company’s commercial business and renewed dedication to offering the most innovative commercial product offerings and intelligent services to clients across the pharmaceutical industry. They also join veteran epocrates leader, Debbie Alcott, who will lead sales strategy and optimization.